Advisory Services Network’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.52M Sell
13,001
-1,235
-9% -$593K 0.07% 272
2026
Q1
$7M Buy
14,236
+3,291
+30% +$1.79M 0.09% 223
2025
Q4
$6.34M Buy
10,945
+528
+5% +$299K 0.09% 230
2025
Q3
$5.05M Sell
10,417
-2,338
-18% -$1.09M 0.07% 288
2025
Q2
$5.97M Buy
12,755
+4,648
+57% +$1.94M 0.1% 225
2025
Q1
$4.03M Sell
8,107
-796
-9% -$431K 0.08% 293
2024
Q4
$4.63M Sell
8,903
-252
-3% -$139K 0.09% 257
2024
Q3
$5.06M Hold
9,155
0.1% 203
2024
Q2
$5.06M Buy
9,155
+286
+3% +$164K 0.1% 203
2024
Q1
$5.15M Buy
8,869
+231
+3% +$130K 0.11% 204
2023
Q4
$4.58M Sell
8,638
-532
-6% -$258K 0.11% 206
2023
Q3
$4.64M Buy
9,170
+162
+2% +$86.3K 0.12% 186
2023
Q2
$4.7M Sell
9,008
-636
-7% -$343K 0.13% 194
2023
Q1
$5.56M Sell
9,644
-917
-9% -$517K 0.15% 152
2022
Q4
$5.82M Buy
10,561
+1,061
+11% +$562K 0.18% 126
2022
Q3
$4.82M Buy
9,500
+742
+8% +$415K 0.17% 142
2022
Q2
$4.76M Buy
8,758
+549
+7% +$302K 0.16% 148
2022
Q1
$4.85M Sell
8,209
-860
-9% -$494K 0.14% 172
2021
Q4
$6.05M Buy
9,069
+1,141
+14% +$712K 0.17% 133
2021
Q3
$4.53M Buy
7,928
+198
+3% +$109K 0.14% 178
2021
Q2
$3.9M Buy
7,730
+28
+0.4% +$13.2K 0.12% 208
2021
Q1
$3.52M Sell
7,702
-3,412
-31% -$1.63M 0.13% 202
2020
Q4
$5.18M Buy
11,114
+2,769
+33% +$1.3M 0.21% 113
2020
Q3
$3.68M Sell
8,345
-1,547
-16% -$639K 0.17% 149
2020
Q2
$3.58M Sell
9,892
-1,344
-12% -$450K 0.2% 135
2020
Q1
$3.19M Buy
11,236
+1,587
+16% +$500K 0.21% 120
2019
Q4
$3.14M Buy
9,649
+272
+3% +$82.5K 0.16% 154
2019
Q3
$2.75M Hold
9,377
0.17% 150
2019
Q2
$2.75M Buy
9,377
+910
+11% +$251K 0.17% 150
2019
Q1
$2.32M Buy
8,467
+1,105
+15% +$275K 0.16% 163
2018
Q4
$1.65M Sell
7,362
-906
-11% -$213K 0.14% 182
2018
Q3
$2.02M Sell
8,268
-280
-3% -$64.4K 0.15% 180
2018
Q2
$2M Buy
8,548
+98
+1% +$20.8K 0.15% 178
2018
Q1
$1.75M Buy
8,450
+376
+5% +$78.9K 0.14% 192
2017
Q4
$1.53M Buy
8,074
+606
+8% +$116K 0.13% 207
2017
Q3
$1.41M Sell
7,468
-382
-5% -$69.2K 0.16% 163
2017
Q2
$1.37M Buy
7,850
+957
+14% +$161K 0.18% 147
2017
Q1
$1.06M Buy
+6,893
New +$1.05M 0.15% 169
2016
Q3
$1.01M Buy
6,342
+82
+1% +$12.6K 0.19% 128
2016
Q2
$925K Sell
6,260
-379
-6% -$55.9K 0.21% 114
2016
Q1
$940K Buy
6,639
+152
+2% +$20.4K 0.26% 93
2015
Q4
$920K Buy
6,487
+202
+3% +$26.9K 0.3% 80
2015
Q3
$769K Sell
6,285
-176
-3% -$22.9K 0.23% 92
2015
Q2
$844K Sell
6,461
-158
-2% -$20.6K 0.25% 88
2015
Q1
$884K Buy
6,619
+265
+4% +$34.2K 0.24% 87
2014
Q4
$796K Sell
6,354
-2,263
-26% -$275K 0.25% 91
2014
Q3
$1.05M Buy
8,617
+64
+0.7% +$7.78K 0.38% 57
2014
Q2
$1.01M Buy
8,553
+76
+0.9% +$8.94K 0.43% 62
2014
Q1
$1.02M Buy
8,477
+1,377
+19% +$164K 0.53% 47
2013
Q4
$791K Buy
+7,100
New +$706K 0.4% 65

Other funds holding TMO

Advisory Services Network's TMO Position: Q2 2026 in Review

Advisory Services Network reduced its Thermo Fisher Scientific (TMO) stake by 8.7% in Q2 2026, selling an estimated $593K and leaving 13,001 shares worth $6.52M. The position accounts for 0.07% of the portfolio, ranked #272.

Advisory Services Network first reported a position in TMO in Q4 2013 and has held it in 50 quarters since. The position peaked at $7M in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Advisory Services Network held 13,001 shares of Thermo Fisher Scientific worth $6.52M as of Q2 2026.
  • Advisory Services Network sold 1,235 Thermo Fisher Scientific shares in Q2 2026, an estimated $593K.
  • Thermo Fisher Scientific made up 0.07% of Advisory Services Network's portfolio in Q2 2026, its #272 holding.
  • Advisory Services Network first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 50 quarters since.
  • Advisory Services Network's Thermo Fisher Scientific position peaked at $7M in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.